Tirzepatide
A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 160
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.